Neurofibromatosis and the COVID-19 Vaccine
Many individuals with NF have concerns about whether their NF diagnosis places them at additional risk of side effects from…
Read MoreCheck out past blogs and news!
Many individuals with NF have concerns about whether their NF diagnosis places them at additional risk of side effects from…
Read MoreJoin us to celebrate the people, the programs, and the supporters of NF Midwest. It will be a casual hour…
Read MoreCheck out our Summer 2021 NF Midwest Newsletter! The highlights of this issue include… Page 1 Page 2 Page 3…
Read MoreResearchers are looking for at least 1,000 people over the age of 40 with NF1 to participate in an exciting…
Read MoreNF Midwest has awarded three $1,000 post-secondary academic scholarships and one new Distinguished Service Scholarship to four adults affected by…
Read MoreIf you struggle with pain from NF1, you are invited to participate in a clinical trial to evaluate a chronic…
Read MoreKalona is selling her art and plants to support NF1. Her granddaughter has neurofibromatosis and I am trying to help…
Read MoreAn update of the diagnostic criteria for neurofibromatosis type 1 has just been published in Genetics in Medicine, the official…
Read MoreAre you a young adult living with NF and want to make a difference in your community? In addition to…
Read MoreCamp New Friends, run by Brainy Camps from the Children’s National Medical center has redesigned its programming this summer to…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.